Biocidal products must be phased off the GB market. The active substance/product type combinations listed are due to expire under the GB Biocidal Products Regulation (GB BPR) on the following dates: 31 December 2025 N-(dichlorofluoromethylthio)-Nâ²,Nâ²-dimethyl-N-phenylsulfamide (dichlofluanid) (CAS 1085-98-9 EC 214-118-7) in product type 21 N-(trichloromethylthio)phthalimide (folpet) (CAS 133-07-3 EC 205-088-6) in product type 6 Dichloro-N-[(dimethylamino)sulphonyl] fluoro-N-(ptolyl)methanesulphenamide (tolylfluanid) (CAS 731-27-1 EC 211-986-9) in product type 21 Copper flakes (coated with aliphatic acids) (CAS 7440-50-8 EC 231-159-6) in product type 21
30 June 2026 Bacillus sphaericus 2362, strain ABTS-1743 (CAS 143447-72-7 EC N/A) in product type 18 Bacillus thuringiensis subsp. israelensis, strain SA3A (CAS N/A EC N/A) in product type 18 30 September 2026 N-(trichloromethylthio)phthalimide (folpet) (CAS 133-07-3 EC 205-088-6) in product type 7 (E)-1-(2-chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine (clothianidin) (CAS 210880-92-5 EC 433-460-1) in product type 18 Â Once the approvals expire, the active substances will no longer be able to be used in biocidal products of the relevant product types in GB. In addition, articles treated with such products will no longer be able to be placed on the market in GB. If you hold an affected GB BPR product authorisation or Control of Pesticides Regulations (COPR) product approval, we will contact you about cancelling or revoking your authorisation or approval. You will have an opportunity to submit comments or additional information and we will take account of these when finalising our decision. If you are aware of any disproportionate negative impacts that are likely to arise from the expiry of the active substance/product type combinations listed, please contact us. This applies to biocidal active substance/product type combinations which expire between 1 January 2024 and 31 December 2026. The active substance/product type combinations are able to be postponed providing a timely renewal application has been submitted and accepted. HSE provided information about the decision to postpone expiry dates in a previous ebulletin. The requirements have now been met for the following active substance/product type combination: From 30 November 2026 to 31 January 2027 IPBC (3-iodo-2-propynylbutylcarbamate) (CAS 55406-53-6 EC 259-627-5) in product type 13
If you want to supply new biocidal products containing this active substance, you can still apply for GB BPR product authorisation. New products (including new trade names) must not be supplied in GB until product authorisation is granted. HSE will provide separate updates on the renewal decisions and future expiry date postponements captured within this overall decision when relevant. | 